Home / Share Price Target / Novartind
Novartis India Share Price Target 2024, 2025, 2026 to 2039 With Charts
Novartis India Limited | |||
 | Symbol: NOVARTIND | ||
| Price: ₹672.25 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Novartis India Brief Company Overview
- 1.1: Novartis India Limited: A Healthcare Leader in India
- 1.2: Novartis India Financial Performance
- 1.2.1: Is Novartis India A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Novartis India Share Price Target For 2024
- 2.1.1: Novartis India Share Price Target Table For 2024
- 2.1.2: Summary: Novartis India Share Price Prediction For 2024
- 2.2: Novartis India Share Price Target For 2025
- 2.2.1: Novartis India Share Price Target Table For 2025
- 2.2.2: Summary: Novartis India Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Novartis India Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Novartis India Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Novartis India Past Performance
Novartis India Brief Company Overview
Novartis India Limited: A Healthcare Leader in India
Novartis India Limited, established in 1947 and headquartered in Mumbai, is a prominent healthcare company operating in India. As a subsidiary of the global healthcare giant Novartis AG, the company has gained a strong reputation for providing innovative therapeutic solutions.
Novartis India's diverse product portfolio includes bone and pain products under the Voveran brand, transplantation immunology products under brands like Simulect and Certican, and neurosciences products under Tegrital and Exelon. This wide range of offerings caters to a variety of healthcare needs.
The company's commitment to innovation and patient care is evident in its research and development efforts. With a focus on areas like cardiovascular health, cancer, and neurology, Novartis India strives to develop and deliver cutting-edge treatments to patients.
Advertisement
Novartis India Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,747.7 Crore | Market valuation of Novartis India's shares. |
| Revenue (TTM) | 336.76 Crore | Total revenue generated by Novartis India over the past twelve months. |
| Net Income (TTM) | +90.67 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 25.37% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 26.92% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +1.9% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +27% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 0.93 | Company's total debt divided by total shareholder equity. |
| Total Debt | 6.97 Crore | Sum of Novartis India's current & long-term financial obligations. |
| Total Cash | 584.98 Crore | Total amount of liquid funds available to Novartis India. |
| Beta | 0.34 | Beta is less than 1 indicating that the Novartis India's price is less volatile than the market. |
Is Novartis India A Good Buy For Long Term?
No valid response content found
To predict the Novartis India's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Novartis India Share Price Target For 2024
The line chart displays the monthly closing prices of Novartis India with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Novartis India shares in 2024, see the table below.
Advertisement
Novartis India Share Price Target Table For 2024
| Novartis India's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 735.90 (+9.46%) | Price Action: Aug 2014 High |
| 2024 Target 2 | 728.55 (+8.37%) | Technical Indicator: MA150 |
| 2024 Target 1 | 720.00 (+7.1%) | Price Action: Dec 2004 High |
| Current Price | 672.25 | Novartis India's 1 share price as of Wed 06 Dec 2023 |
| Stop Loss 1 | 629.00 (-6.44%) | Price Action: Mar 2021 High |
| Stop Loss 2 | 621.00 (-7.63%) | Price Action: Jun 2018 Low |
| Stop Loss 3 | 613.00 (-8.82%) | Price Action: Jan 2023 Low |
Summary: Novartis India Share Price Prediction For 2024
In summary, Novartis India has declined by ₹-2.75, recording a notable -0.41% decrease from 1st January 2024 to 06 Dec 2023. Despite the setback, our analysis of Novartis India for 2024 predicts an additional rise of 7.1% to 9.46% by the end of 2024 with three potential targets T1: 720.00, T2: 728.55, T3: 735.90. Stop Loss at SL1: 629.00, SL2: 621.00, SL3: 613.00.
Novartis India has a 52-week high of ₹909.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹537.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Novartis India.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Novartis India Share Price Target For 2025
The line chart displays the monthly closing prices of Novartis India with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Novartis India shares in 2025, see the table below.
Advertisement
Novartis India Share Price Target Table For 2025
| Novartis India's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 896.71 (+33.38%) | Price Action: Chart |
| 2025 Target 2 | 879.99 (+30.9%) | Price Action: Chart |
| 2025 Target 1 | 871.28 (+29.6%) | Fibonacci Extension Level 100% |
| Current Price | 672.25 | Novartis India's 1 share price as of Wed 06 Dec 2023 |
| Stop Loss 1 | 613.00 (-8.82%) | Price Action: Jan 2023 Low |
| Stop Loss 2 | 605.90 (-9.87%) | Price Action: Feb 2006 High |
| Stop Loss 3 | 598.00 (-11.05%) | Price Action: Feb 2018 Low |
Summary: Novartis India Share Price Prediction For 2025
In summary, Novartis India has declined by ₹-2.75, recording a notable -0.41% decrease from 1st January 2024 to 06 Dec 2023. Despite the setback, our analysis of Novartis India for 2025 predicts an additional rise of 29.6% to 33.38% by the end of 2025 with three potential targets T1: 871.28, T2: 879.99, T3: 896.71. Stop Loss at SL1: 613.00, SL2: 605.90, SL3: 598.00.
Novartis India has a All-Time high of ₹1098.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹537.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Novartis India, we have created a specific page for that check here: Novartis India Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Novartis India Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Novartis India share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 1.76% over the next 15 years.
For complete year by year Novartis India long term share price target from 2024, 2025 to 2039 check the below table.
Novartis India Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Novartis India Target | YoY Change % |
|---|---|---|
| 2024 | ₹672.25 | [Current Price] |
| 2024 | ₹716.56 | 6.59% |
| 2025 | ₹718.63 | 0.28% |
| 2026 | ₹733.18 | 2.02% |
| 2027 | ₹760.46 | 3.72% |
| 2028 | ₹776.02 | 2.04% |
| 2029 | ₹789.06 | 1.68% |
| 2030 | ₹789.89 | 0.1% |
| 2031 | ₹804.48 | 1.84% |
| 2032 | ₹832.99 | 3.54% |
| 2033 | ₹848.66 | 1.88% |
| 2034 | ₹861.56 | 1.52% |
| 2035 | ₹861.16 | -0.05% |
| 2036 | ₹875.77 | 1.69% |
| 2037 | ₹905.53 | 3.39% |
| 2038 | ₹921.29 | 1.74% |
| 2039 | ₹914.6 | -0.73% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Novartis India Past Performance
- In 1990, Novartis India opening price was ₹114
- As of Wed 06 Dec 2023 the price stands at ₹672.25.
- This represents a Compound Annual Growth Rate (CAGR) of 5.36%.
- In 33 years, an investment of 10,000 would have become ₹58,969.29.
As we wrap up, we hope you like our study on Novartis India share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Novartis India Share Price History
- Novartis India Price Target Tomorrow
- Novartis India Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
